Showing results (131-140 of 186) with videos related to
Sort By:
Pageof 19
Chest|December 12, 2007
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?Jin Won Huh, Dong Soon Kim, Yeon-Mok Oh, et al.Chest|April 3, 2007
Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosisI-Nae Park, Dong Soon Kim, Tae Sun Shim, et al.Plos One|March 18, 2015
AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cellsYun Jung Choi, Seon Ye Kim, Kwang Sup So, et al.Journal of Korean Medical Science|January 1, 2019
Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung CancerYoung Ju Jung, In-Jae Oh, Youndong Kim, et al.Respirology (Carlton, Vic.)|July 6, 2011
Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7daysJin Won Huh, Hye-Sook Choi, Chae-Man Lim, et al.Oncotarget|September 24, 2017
Multiple receptor tyrosine kinase activation related to ALK inhibitor resistance in lung cancer cells with ALK rearrangementSe Hoon Choi, Dong Ha Kim, Yun Jung Choi, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 11, 2002
The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumoniaDong Soon Kim, Bin Yoo, Jin Sung Lee, et al.Plos One|December 9, 2014
Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790MKwang Sup So, Cheol Hyeon Kim, Jin Kyung Rho, et al.International Journal of Clinical and Experimental Pathology|November 18, 2014
Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancerHo-Cheol Kim, Joon Seon Song, Jae Cheol Lee, et al.Molecular Psychiatry|September 29, 2023
Network biomarkers in recovered psychosis patients who discontinued antipsychoticsSoyolsaikhan Odkhuu, Woo-Sung Kim, Uyanga Tsogt, et al.Pageof 19